Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic is a research paper published in The FASEB Journal (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: DEO29661
NCI NIH HHS
Grant: R21 CA231000
FWCI
1.42
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals